Abstract
Introduction

Mesenchymal stem cells (MSCs) offer enormous promise in emerging strategies of cell-based therapeutics to promote the regeneration of damaged tissues and to modify the natural history of many diseases
. One attractive feature of MSCs is their ability to differentiate into multiple cell types, which makes them useful for tissue regeneration strategies to replace damaged, impaired or dead cells and tissues, either by cell replacement therapy [5] [6] or in combination with a scaffold for tissue engineering [7] . MSCs also exert trophic functions in the environment of damaged tissues that promote endogenous wound healing mechanisms [8] , such as promoting angiogenesis [9] [10] , reducing fibrosis [11] and modulating inflammation [12] . In particular, the immunoregulatory properties of MSCs have # These co-senior authors contributed equally to this work. made them a useful therapeutic for the treatment of graft versus host disease [13] . Although the pro-regeneration functions of MSCs make them applicable for a variety of other clinical applications, there are significant challenges that limit their widespread use, including optimization of methods to harvest the cells, expand them ex vivo, and in the case of allogeneic MSCs, to transport and store the cells prior to implantation [14] . Many of these limitations could be overcome by using autogenic MSCs that can be harvested and used as a therapeutic agent at the point of clinical care [15] . [16] , the plastic-adherent cells isolated from traumatized muscle can be harvested in substantially higher numbers [17] . We refer to this population as mesenchymal progenitor cells (MPCs) to indicate that these cells are likely to be the descendants of stem cells (e.g. pericytes [18] ) but are proliferating in the tissue at the time of harvest. The morphology and cell surface epitope profiles of MPCs are similar to those of bone marrow derived MSCs, and they give rise to colony-forming unit fibroblasts, an indicator of a clonogenic, multipotent cell population [19] . Although [20] . It has been suggested that nonmuscle progenitors participate in the process of muscle regeneration by facilitating the reparative function of myoblasts and myofibroblasts [21] and that the migration of MPCs into the traumatized muscle may be a part of the normal wound healing response [22] .
Our laboratory has recently identified a novel population of cells in traumatically injured muscle tissue that resemble MSCs. Although multipotent stem cells have previously been isolated from untraumatized muscle using immuno-selective techniques
the MPCs were capable of differentiation into osteoblasts, adipocytes and chondrocytes, they appeared to have a distinct osteogenic gene expression profile, which likely reflects their different tissue of origin and in vivo function
The traumatized muscle derived MPCs could be a useful cell source for cell-based therapies that follow musculoskeletal injury, particularly those related to orthopaedic reconstruction [23] . MPCs have been harvested from surgically debrided tissues from the wound margins of extremity injuries [19] 
Materials and methods
MPC harvest
Traumatically injured muscle was collected with informed consent and Institutional Review Board approval from the Walter Reed Army Medical Center using a previously described method [17, 19] 
Immunophenotyping
Flow cytometry was performed on cells at the end of the second passage as previously described [17] . 
Mixed lymphocyte reaction
Peripheral blood from healthy human donors was collected into heparinized containers (BD Biosciences), and mononuclear cells (PBMC)
were isolated by Ficoll-Hypaque density-gradient centrifugation as described previously [25] . 
Statistical methods
Statistical significance for all tests was assigned to P Ͻ 0.05 except for RT-PCR array gene expression levels, for which statistical significance was assigned to P Ͻ 0.018 to limit the false discovery rate.
Results
The phenotype of traumatized muscle derived MPCs was similar to other populations of MSCs
The traumatized muscle exhibited substantial histological evidence of tissue damage (Fig. 1A) . Within 
Multilineage differentiation activity of MPCs was lower than bone marrow MSCs
Under appropriate induction conditions, both cell types exhibited evidence of osteogenic, adipogenic and chondrogenic differentiation (Fig. 3A) . (Fig. 3C) , the up-regulation of surface ALP in MPCs was significantly lower than MSCs under osteogenic conditions (Fig. 3B) . Chondrogenic differentiation by MPCs was particularly limited, as they produced significantly smaller pellets, less sGAG per cell, and less overall sGAG than the bone marrow derived MSCs (Fig. 4D-F) . Fig. 4C ), or baseline expression of PPARG2, SOX9 and RUNX2, the master regulators of adipogenesis, chondrogenesis and osteogenesis, respectively (Fig. 4D) (Fig. 5A) . The immunoregulatory function of the MPCs was verified using a mixed lymphocyte reaction assay (Fig. 5B) (Fig. 6A) , and the production of VEGFA, a potent angiogenic factor, by MPCs was verified in Western blots (Fig. 6B) Variations in differentiation potential [34] and trophic function [35, 36] of MSCs have previously been correlated with the age and sex of the donors from which the cells were harvested. The precise mechanism leading to these changes in MSC function are not completely understood, although age related changes have been attributed to telomere shortening [37] , and the sex dimorphisms appear to be generated by preconditioning of the MSCs by sex hormones prior to harvest [38] . In the context of these donor effects, the differences in traumatized muscle derived MPCs and bone marrow derived MSCs can be examined in greater detail. The substantially higher yield of harvested MPCs relative to MSCs is not consistent with the changes in cellularity that might be attributable to donor age or sex [38, 39] [18] . The MPCs may be an activated descendent of the myoendothelial/pericyte cell types that have (1) been activated in response to traumatic injury, (2) down-regulated the expression of surface proteins required for their vascular niche [45] and (3) began to proliferate in the tissue [22] . There is also recent evidence indicating that a multipotential progenitor cell population may be derived from the vasculature via epithelial to mesenchymal transition in response to injury [46] . Taken together, these studies suggest that the MPCs may arise from the vasculature in large numbers following trauma, and they may participate in the wound healing process by secreting trophic factors to promote tissue regeneration by mechanisms similar to those used by the myoendothelial cells and pericytes [47] .
MPCs exhibit regenerative properties that are characteristic of MSCs
(Fig. 4A). No difference was detected between the two cell types in gene-expression levels of the MSC markers CD44 and ENG (CD105;
. The pro-angiogenic potential of MPCs was assayed by measuring the effect of their secreted factors on the proliferation of microvascular endothelial cells (Fig. 6C). Similar to bone marrow derived MSCs, the MPCs secreted factors that significantly increased microvascular endothelial cell proliferation within 48 hrs of initial seeding, and there were no significant differences between the effects of the MPC or MSC secreted factors.
Discussion
MSCs may be a useful cell type for a variety of applications in regenerative medicine, although there is currently no clear
Fig. 2 Cell surface epitope profile of traumatized muscle derived MPCs. (A) MPC cell surface marker expression (black dots) compared to isotype control (grey dots) were compared using flow cytometry. All antibodies were PE conjugated (red), and the percentage of events with elevated FL-2 fluorescence is indicated in each panel (mean Ϯ S.D. for n ϭ 4). (B) The fluorescence intensity of positive surface markers was compared between MPCs and bone marrow derived MSCs. *P Ͻ 0.05, Student's t-tests with n ϭ 4, † the fluorescence intensity of CD90 is 10ϫ greater than the other surface markers and is depicted using the right axis. consensus on the best method of sourcing and isolating MSCs for clinical use. In this study, we have evaluated a recently identified population of traumatized muscle derived MPCs by quantitatively comparing them to a typical population of bone marrow derived MSCs. The traumatized muscle tissue is an attractive source of autolgous cells with MSC-like properties, as it is readily obtained © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 3 Trilineage differentiation of traumatized muscle derived MPCs. (A) Histological evidence of differentiation in MPCs compared to bone marrow derived MSCs grown in GM, OM, AM and chondrogenic induction medium with (TGF-␤
Fig. 4 qPCR array for MSC genes. (A) Comparison of the gene expression profiles for traumatized muscle derived MPCs and bone marrow derived MSCs. Genes with 4-fold differential expression (indicated by dashed lines) are labelled and select genes are listed in the adjacent table. (B) A volcano plot comparing the fold-difference in cytokine gene expression (x-axis; vertical dashed lines indicating 4-fold differential expression) to the statistical significance (y-axis; horizontal dashed line indicating P Ͻ 0.05). Bar graphs comparing: (C) specific MSC Markers (THY1
The MPCs may also be descendants of bone marrow derived MSCs that entered the traumatized tissue via the bloodstream while homing to the site of injury [48] . Some differences were detected between the MPCs and bone marrow derived MSCs, and these differences may reflect the tissues from which they were harvested and the extracellular environment immediately prior to harvest. The MPCs exhibited higher metabolic activity than the MSCs, which may indicate that they undergo mitochondrial biogenesis in response to injury and to prepare them for their contribution to the wound healing response [49] . The differences in the baseline gene expression profile may also be justified given that MPCs were in the regenerating muscle tissue at the time of harvest, whereas the MSCs were in their bone marrow niche [20] . For example, the MSCs expressed higher levels of VCAM1, which is characteristic of genes associated with bone physiology and maintenance by the marrow stroma [50] , whereas the MPCs expressed higher levels of genes that indicate neuromuscular differentiation: THY1 [51] and NES [52] . It [54, 55] . MPCs may also be useful to manage graft versus host disease following transplant of orthopaedic tissues [56] . 
